Healthcare -
Biotechnology - NASDAQ - US
$ 9.94
7.81 %
$ 220 M
Market Cap
-4.56
P/E
INMB - LONG-TERM DEBT
Long-term Debt INMB - INmune Bio, Inc.
397 K
LAST VALUE
-83.82%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR